KJT Group

Gold Sponsor

KJT Group is a leading healthcare market research and consulting firm specializing in rare diseases and orphan drugs. With a strong focus on patient-centric research, they provide valuable insights to pharmaceutical companies, biotech firms, and healthcare organizations to help them understand patient needs, market dynamics, and strategic opportunities in the orphan drug space. KJT Group's expertise in designing and conducting research studies tailored to the unique challenges of rare diseases makes them a trusted partner for companies looking to make a meaningful impact in the orphan drug market.